TFS Chemicals - Aspire
Pharma Focus America
Sino Biological - Cytokine

Elekta and MSD Collaborate to Improve Kidney Cancer Care Through Digital Solutions

Thursday, March 28, 2024

Elekta (EKTA-B.ST) has announced a new partnership with MSD (Merck & Co., Inc., Rahway, N.J., USA) focused on advancing digital patient monitoring for individuals dealing with advanced renal cell carcinoma (RCC). This collaboration will utilize Elekta’s Kaiku Health solution, a digital platform designed to engage patients and monitor outcomes.

In the current landscape, immuno-oncology (IO)-based combination therapy has become the standard of care for frontline advanced RCC. This includes IO-tyrosine kinase inhibitors* (TKI) for favorable and intermediate-to-poor risk patients, or IO-IO for intermediate-to-poor risk patients. Despite its efficacy, managing potential side effects is a critical concern for healthcare providers.

Elekta, with support from MSD, aims to develop a digital module for patients to stay connected with their care teams and educate them about their disease, treatment, and potential side effects. This module will feature comprehensive symptom monitoring and patient support, providing tailored and timely tracking of symptoms. It will also offer digital educational materials specifically designed for IO-TKI combination therapy in advanced RCC. The validation of this module is planned for 2024, in collaboration with several leading cancer clinics in Europe.

Marc Gailhardou, Vice President, Global Oncology Marketing at MSD, emphasized their commitment to innovation in kidney cancer care and genitourinary cancers through this collaboration. Anish Patankar, SVP & Head of Business Line Software at Elekta, highlighted the importance of improving communication between patients and their care teams, aiming to provide structured support for symptom management and monitoring while educating patients about their disease and treatment.



patheon - Mastering API production at every scaleWorld Vaccine Congress Europe 2024World Orphan Drug Congress 2024Future Labs Live USA 2024patheon - Revolutionizing PharmaHealthcare CNO SummitHealthcare CMO Summit